{"transactions":[{"id":858324,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:33:25.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":17638,"price":13.3,"value":234585.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":422570,"source":{"system":"sec-edgar","filing":"0001822014-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000003/primarydocument.xml","form_type":"4"}},{"id":867063,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":7228,"price":13.67,"value":98806.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":440208,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867062,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2410,"price":13.67,"value":32944.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":447436,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867061,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-02-28","kind":"grant","planned":false,"acquired":true,"shares":23818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":449846,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":867060,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T21:09:18.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":11541,"price":13.75,"value":158688.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":426028,"source":{"system":"sec-edgar","filing":"0001822014-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000182201426000002/primarydocument.xml","form_type":"4"}},{"id":1045818,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-09-08T11:10:52.000Z","date":"2025-09-05","kind":"purchase","planned":false,"acquired":true,"shares":81550,"price":12.2239,"value":996859.045,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On the transaction date, the reporting person purchased 81,550 shares in multiple trades at prices ranging from $12.02 to $12.47.  The price reported above reflects the weighted average purchase price.  The reporting person hereby undertakes to provide to the Staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":437569,"source":{"system":"sec-edgar","filing":"0001562180-25-006130","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025006130/primarydocument.xml","form_type":"4"}},{"id":1097821,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:19:31.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":833,"price":15.13,"value":12603.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2025."}],"balance_after":356019,"source":{"system":"sec-edgar","filing":"0001562180-25-005186","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025005186/primarydocument.xml","form_type":"4"}},{"id":1219525,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-06T21:39:55.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":224123,"price":18.19,"value":4076797.37,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 224,123 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates."}],"balance_after":224123,"derivative":{"exercise_price":18.19,"exercise_date":"2026-03-04","expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":224123},"source":{"system":"sec-edgar","filing":"0001562180-25-002156","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002156/primarydocument.xml","form_type":"4"}},{"id":1219524,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:39:55.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":151181,"price":18.19,"value":2749982.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":355186,"source":{"system":"sec-edgar","filing":"0001562180-25-002156","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025002156/primarydocument.xml","form_type":"4"}},{"id":1228346,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T21:19:00.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":2053,"price":18.5363,"value":38055.0239,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On the transaction date, the reporting person sold 2,053 shares in multiple trades at prices ranging from $18.02 to $18.9918.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":204005,"source":{"system":"sec-edgar","filing":"0001562180-25-001975","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001975/primarydocument.xml","form_type":"4"}},{"id":1235741,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:48.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":2341,"price":18.2843,"value":42803.5463,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 28, 2025, the reporting person sold 2,341 shares in multiple trades at prices ranging from $18.175 to $18.765.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":206058,"source":{"system":"sec-edgar","filing":"0001562180-25-001916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001916/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235740,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:48.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":1808,"price":20.549,"value":37152.592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 27, 2025, the reporting person sold 1,808 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":208399,"source":{"system":"sec-edgar","filing":"0001562180-25-001916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001916/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235739,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T02:26:48.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":9345,"price":19.9219,"value":186170.1555,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 9,345 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":210207,"source":{"system":"sec-edgar","filing":"0001562180-25-001916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001916/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1235724,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:26:55.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":2341,"price":18.2843,"value":42803.5463,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 28, 2025, the reporting person sold 2,341 shares in multiple trades at prices ranging from $18.175 to $18.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":206058,"source":{"system":"sec-edgar","filing":"0001562180-25-001833","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001833/primarydocument.xml","form_type":"4"}},{"id":1235723,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:26:55.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":1808,"price":20.549,"value":37152.592,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 1,808 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":208399,"source":{"system":"sec-edgar","filing":"0001562180-25-001833","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001833/primarydocument.xml","form_type":"4"}},{"id":1235722,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:26:55.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":9345,"price":19.9219,"value":186170.1555,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, the reporting person sold 9,345 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":210207,"source":{"system":"sec-edgar","filing":"0001562180-25-001833","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025001833/primarydocument.xml","form_type":"4"}},{"id":1314720,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-03T21:04:20.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":373,"price":14.748,"value":5501.004,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2024 through December 31, 2024. This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2024."}],"balance_after":219552,"source":{"system":"sec-edgar","filing":"0001562180-25-000066","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025000066/primarydocument.xml","form_type":"4"}},{"id":1439623,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-06T20:19:03.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1286,"price":12.24,"value":15740.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2024 through June 30, 2024.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2024."}],"balance_after":220465,"source":{"system":"sec-edgar","filing":"0001562180-24-006040","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024006040/primarydocument.xml","form_type":"4"}},{"id":1440742,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-05T20:25:19.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":688,"price":20.1416,"value":13857.4208,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":219179,"source":{"system":"sec-edgar","filing":"0001562180-24-005984","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024005984/primarydocument.xml","form_type":"4"}},{"id":1609998,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-29T21:43:29.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":156348,"price":16.3,"value":2548472.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 156,348 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":156348,"derivative":{"exercise_price":16.3,"exercise_date":"2025-02-27","expiration_date":"2034-02-26","underlying":"Ordinary Shares","underlying_shares":156348},"source":{"system":"sec-edgar","filing":"0001562180-24-001989","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001989/primarydocument.xml","form_type":"4"}},{"id":1609997,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-02-29T21:43:29.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":102249,"price":16.3,"value":1666658.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":219867,"source":{"system":"sec-edgar","filing":"0001562180-24-001989","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024001989/primarydocument.xml","form_type":"4"}},{"id":1751331,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-02T20:20:51.000Z","date":"2023-11-02","kind":"exercise","planned":false,"acquired":false,"shares":175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests 2,686 share(s) on 24-Feb-2019, 6,250 share(s) on 24-Feb-2020"}],"balance_after":0,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":175},"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751330,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-02T20:20:51.000Z","date":"2023-10-31","kind":"exercise","planned":false,"acquired":false,"shares":7752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests 2 share(s) on 22-Feb-2018, 9,750 share(s) on 22-Feb-2021"}],"balance_after":0,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":7752},"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751329,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-02T20:20:51.000Z","date":"2023-10-31","kind":"exercise","planned":false,"acquired":false,"shares":2480,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.44,"exercise_date":"2020-07-27","expiration_date":"2026-07-27","underlying":"Ordinary Shares","underlying_shares":2480},"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751328,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-02T20:20:51.000Z","date":"2023-10-31","kind":"exercise","planned":false,"acquired":false,"shares":7561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests 2,686 share(s) on 24-Feb-2019, 6,250 share(s) on 24-Feb-2020"}],"balance_after":175,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":7561},"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751327,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-11-02T20:20:51.000Z","date":"2023-11-02","kind":"exercise","planned":false,"acquired":true,"shares":175,"price":11.46,"value":2005.5,"ownership":{"direct":true},"balance_after":117618,"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751326,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-11-02T20:20:51.000Z","date":"2023-10-31","kind":"exercise","planned":false,"acquired":true,"shares":7752,"price":7.15,"value":55426.8,"ownership":{"direct":true},"balance_after":117443,"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751325,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-11-02T20:20:51.000Z","date":"2023-10-31","kind":"exercise","planned":false,"acquired":true,"shares":2480,"price":11.44,"value":28371.2,"ownership":{"direct":true},"balance_after":109691,"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1751324,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-11-02T20:20:51.000Z","date":"2023-10-31","kind":"exercise","planned":false,"acquired":true,"shares":7561,"price":11.46,"value":86649.06,"ownership":{"direct":true},"balance_after":107211,"source":{"system":"sec-edgar","filing":"0001562180-23-007502","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023007502/primarydocument.xml","form_type":"4"}},{"id":1789186,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-09-05T20:24:39.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":883,"price":21.8172,"value":19264.5876,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":99650,"source":{"system":"sec-edgar","filing":"0001562180-23-006686","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023006686/primarydocument.xml","form_type":"4"}},{"id":1814949,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-08-04T20:02:21.000Z","date":"2023-08-02","kind":"sale","planned":false,"acquired":false,"shares":1144,"price":30.2511,"value":34607.2584,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":100533,"source":{"system":"sec-edgar","filing":"0001562180-23-006182","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023006182/primarydocument.xml","form_type":"4"}},{"id":1833829,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-07-06T20:13:24.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":367,"price":35.28,"value":12947.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January1, 2023 through June 30, 2023.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023."}],"balance_after":101677,"source":{"system":"sec-edgar","filing":"0001562180-23-005757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023005757/primarydocument.xml","form_type":"4"}},{"id":1965770,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:51:15.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":775,"price":76.1594,"value":59023.535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":101310,"source":{"system":"sec-edgar","filing":"0001562180-23-002578","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002578/primarydocument.xml","form_type":"4"}},{"id":1965769,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:51:15.000Z","date":"2023-03-03","kind":"sale","acquired":false,"shares":4730,"price":76.1594,"value":360233.962,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":102085,"source":{"system":"sec-edgar","filing":"0001562180-23-002578","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002578/primarydocument.xml","form_type":"4"}},{"id":1969090,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T21:40:12.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":11808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents vesting of performance-based restricted stock units."}],"balance_after":106815,"source":{"system":"sec-edgar","filing":"0001562180-23-002490","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002490/primarydocument.xml","form_type":"4"}},{"id":1969089,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-06T21:40:12.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":1055,"price":75.2779,"value":79418.1845,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":95007,"source":{"system":"sec-edgar","filing":"0001562180-23-002490","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023002490/primarydocument.xml","form_type":"4"}},{"id":1979484,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2023-03-02T21:55:26.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":39614,"price":76.97,"value":3049089.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 39,614 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":39614,"derivative":{"exercise_price":76.97,"exercise_date":"2024-02-28","expiration_date":"2033-02-27","underlying":"Ordinary Shares","underlying_shares":39614},"source":{"system":"sec-edgar","filing":"0001645113-23-000027","document":"wf-form4_167779410749716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000027/wf-form4_167779410749716.xml","form_type":"4"}},{"id":1979483,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T21:55:26.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":2198,"price":76.3624,"value":167844.5552,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":96062,"source":{"system":"sec-edgar","filing":"0001645113-23-000027","document":"wf-form4_167779410749716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000027/wf-form4_167779410749716.xml","form_type":"4"}},{"id":1979482,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-03-02T21:55:26.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":23818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":98260,"source":{"system":"sec-edgar","filing":"0001645113-23-000027","document":"wf-form4_167779410749716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000027/wf-form4_167779410749716.xml","form_type":"4"}},{"id":2057504,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-01-10T21:18:06.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":66,"price":62.305,"value":4112.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2022 through December 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2022."}],"balance_after":74442,"source":{"system":"sec-edgar","filing":"0001645113-23-000014","document":"wf-form4_167338547170322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511323000014/wf-form4_167338547170322.xml","form_type":"4"}},{"id":2096088,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-12-05T21:33:18.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":2000,"price":7.15,"value":14300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":7752,"derivative":{"exercise_price":7.15,"expiration_date":"2027-02-21","underlying":"Ordinary Shares","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001645113-22-000096","document":"wf-form4_167027597587120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000096/wf-form4_167027597587120.xml","form_type":"4"}},{"id":2096087,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-12-05T21:33:18.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":2000,"price":7.15,"value":14300.0,"ownership":{"direct":true},"balance_after":74376,"source":{"system":"sec-edgar","filing":"0001645113-22-000096","document":"wf-form4_167027597587120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000096/wf-form4_167027597587120.xml","form_type":"4"}},{"id":2165639,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-09-06T21:15:37.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":885,"price":79.037,"value":69947.745,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":72376,"source":{"system":"sec-edgar","filing":"0001645113-22-000077","document":"wf-form4_166249891435026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000077/wf-form4_166249891435026.xml","form_type":"4"}},{"id":2195790,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:45:16.000Z","date":"2022-08-02","kind":"grant","acquired":true,"shares":7122,"price":70.2,"value":499964.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of August 2, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":73261,"source":{"system":"sec-edgar","filing":"0001645113-22-000072","document":"wf-form4_165955948883661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000072/wf-form4_165955948883661.xml","form_type":"4"}},{"id":2210748,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:49:35.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":251,"price":59.075,"value":14827.825,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2022 through June 30, 2022.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022."}],"balance_after":66139,"source":{"system":"sec-edgar","filing":"0001645113-22-000064","document":"wf-form4_165723055863070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000064/wf-form4_165723055863070.xml","form_type":"4"}},{"id":2337543,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-11T21:55:17.000Z","date":"2022-03-03","kind":"exercise","acquired":false,"shares":1200,"price":11.46,"value":13752.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":7736,"derivative":{"exercise_price":11.46,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001645113-22-000032","document":"wf-form4_164703570445119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000032/wf-form4_164703570445119.xml","form_type":"4"}},{"id":2337542,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-11T21:55:17.000Z","date":"2022-03-03","kind":"exercise","acquired":false,"shares":3840,"price":15.6,"value":59904.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":15.6,"expiration_date":"2025-04-22","underlying":"Ordinary Shares","underlying_shares":3840},"source":{"system":"sec-edgar","filing":"0001645113-22-000032","document":"wf-form4_164703570445119.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000032/wf-form4_164703570445119.xml","form_type":"4"}},{"id":2337541,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-11T21:55:17.000Z","date":"2022-03-03","kind":"exercise","acquired":true,"shares":1200,"price":11.46,"value":13752.0,"ownership":{"direct":true},"balance_after":65888,"source":{"system":"sec-edgar","filing":"0001645113-22-000032","document":"wf-form4_164703570445119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000032/wf-form4_164703570445119.xml","form_type":"4"}},{"id":2337540,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-11T21:55:17.000Z","date":"2022-03-03","kind":"exercise","acquired":true,"shares":3840,"price":15.6,"value":59904.0,"ownership":{"direct":true},"balance_after":64688,"source":{"system":"sec-edgar","filing":"0001645113-22-000032","document":"wf-form4_164703570445119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000032/wf-form4_164703570445119.xml","form_type":"4"}},{"id":2341831,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-09T21:51:18.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":759,"price":70.1,"value":53205.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":60848,"source":{"system":"sec-edgar","filing":"0001645113-22-000026","document":"wf-form4_164686266443195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000026/wf-form4_164686266443195.xml","form_type":"4"}},{"id":2347785,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:26:52.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":5140,"price":80.59,"value":414232.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Options to buy 5,140 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":5140,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":5140},"source":{"system":"sec-edgar","filing":"0001645113-22-000022","document":"wf-form4_164669559462387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000022/wf-form4_164669559462387.xml","form_type":"4"}},{"id":2347784,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-03-07T23:26:52.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":37664,"price":80.59,"value":3035341.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options to buy 37,664 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates."}],"balance_after":37664,"derivative":{"exercise_price":80.59,"exercise_date":"2023-03-01","expiration_date":"2032-02-29","underlying":"Ordinary Shares","underlying_shares":37664},"source":{"system":"sec-edgar","filing":"0001645113-22-000022","document":"wf-form4_164669559462387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000022/wf-form4_164669559462387.xml","form_type":"4"}},{"id":2347783,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:26:52.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":556,"price":70.407,"value":39146.292,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":61607,"source":{"system":"sec-edgar","filing":"0001645113-22-000022","document":"wf-form4_164669559462387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000022/wf-form4_164669559462387.xml","form_type":"4"}},{"id":2347782,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:26:52.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":1149,"price":74.498,"value":85598.202,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units listed.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":62163,"source":{"system":"sec-edgar","filing":"0001645113-22-000022","document":"wf-form4_164669559462387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000022/wf-form4_164669559462387.xml","form_type":"4"}},{"id":2347781,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-03-07T23:26:52.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":21508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 1, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":63312,"source":{"system":"sec-edgar","filing":"0001645113-22-000022","document":"wf-form4_164669559462387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000022/wf-form4_164669559462387.xml","form_type":"4"}},{"id":2436839,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-01-12T22:37:25.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":46,"price":63.818,"value":2935.628,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2021 through December 31, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2021."}],"balance_after":41804,"source":{"system":"sec-edgar","filing":"0001645113-22-000005","document":"wf-form4_164202703285939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000005/wf-form4_164202703285939.xml","form_type":"4"}},{"id":2526316,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-11-03T20:11:05.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":209,"price":107.276,"value":22420.684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":41758,"source":{"system":"sec-edgar","filing":"0001645113-21-000114","document":"wf-form4_163597024160717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000114/wf-form4_163597024160717.xml","form_type":"4"}},{"id":2577226,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-09-07T20:37:52.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":828,"price":138.232,"value":114456.096,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amended total to correct prior mathematical error."}],"balance_after":41967,"source":{"system":"sec-edgar","filing":"0001645113-21-000108","document":"wf-form4_163104705924754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000108/wf-form4_163104705924754.xml","form_type":"4"}},{"id":2602302,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":2606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":6375,"derivative":{"exercise_price":69.37,"expiration_date":"2030-03-02","underlying":"Ordinary Shares","underlying_shares":2606},"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602301,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":7298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":5172,"derivative":{"exercise_price":47.04,"expiration_date":"2029-03-21","underlying":"Ordinary Shares","underlying_shares":7298},"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602300,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":2767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":5533,"derivative":{"exercise_price":32.02,"expiration_date":"2028-10-29","underlying":"Ordinary Shares","underlying_shares":2767},"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602299,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":8026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":3297,"derivative":{"exercise_price":21.5,"expiration_date":"2028-02-26","underlying":"Ordinary Shares","underlying_shares":8026},"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602298,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":5927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":19.25,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":5927},"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602297,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested as of the date hereof."}],"balance_after":3840,"derivative":{"exercise_price":15.6,"expiration_date":"2025-04-22","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602296,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"gift","acquired":false,"shares":1733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":44260,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602295,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":2606,"price":140.9,"value":367185.4,"ownership":{"direct":true},"balance_after":45993,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602294,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":2606,"price":69.37,"value":180778.22,"ownership":{"direct":true},"balance_after":48599,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602293,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":7298,"price":140.9,"value":1028288.2,"ownership":{"direct":true},"balance_after":45993,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602292,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":7298,"price":47.04,"value":343297.92,"ownership":{"direct":true},"balance_after":53291,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602291,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":2767,"price":140.9,"value":389870.3,"ownership":{"direct":true},"balance_after":45993,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602290,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":2767,"price":32.02,"value":88599.34,"ownership":{"direct":true},"balance_after":48760,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602289,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":8026,"price":140.902,"value":1130879.452,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 12, 2021, Ms. Cordova sold 8,026 shares in multiple trades at prices ranging from $140.90 to $140.98.  The price reported above reflects the weighted average sale price.  Ms. Cordova hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45993,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602288,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":8026,"price":21.5,"value":172559.0,"ownership":{"direct":true},"balance_after":54019,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602287,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":5927,"price":141.06,"value":836062.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 12, 2021, Ms. Cordova sold 5,927 shares in multiple trades at prices ranging from $140.90 to $141.08.  The price reported above reflects the weighted average sale price.  Ms. Cordova hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":45993,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602286,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":5927,"price":19.25,"value":114094.75,"ownership":{"direct":true},"balance_after":51920,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2602285,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-16T20:40:01.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":10000,"price":15.6,"value":156000.0,"ownership":{"direct":true},"balance_after":45993,"source":{"system":"sec-edgar","filing":"0001645113-21-000103","document":"wf-form4_162914638367403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000103/wf-form4_162914638367403.xml","form_type":"4"}},{"id":2638087,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-07-08T21:35:50.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":100,"price":137.122,"value":13712.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2021 through June 30, 2021.  This transaction is also exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2021."}],"balance_after":35993,"source":{"system":"sec-edgar","filing":"0001645113-21-000087","document":"wf-form4_162578013600784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000087/wf-form4_162578013600784.xml","form_type":"4"}},{"id":2797009,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-10T21:09:34.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":765,"price":130.806,"value":100066.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":35893,"source":{"system":"sec-edgar","filing":"0001645113-21-000046","document":"wf-form4_161541055936007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000046/wf-form4_161541055936007.xml","form_type":"4"}},{"id":2803197,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:23:26.000Z","date":"2021-03-04","kind":"gift","acquired":false,"shares":910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":36658,"source":{"system":"sec-edgar","filing":"0001645113-21-000037","document":"wf-form4_161523857594813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000037/wf-form4_161523857594813.xml","form_type":"4"}},{"id":2803196,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:23:26.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":567,"price":137.554,"value":77993.118,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units vested on March 3, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":37568,"source":{"system":"sec-edgar","filing":"0001645113-21-000037","document":"wf-form4_161523857594813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000037/wf-form4_161523857594813.xml","form_type":"4"}},{"id":2808848,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-03-04T22:52:16.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":20004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 20,004 ordinary shares will vest and become exercisable in equal installments on each of March 2, 2022, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates."}],"balance_after":20004,"derivative":{"exercise_price":153.09,"expiration_date":"2031-03-01","underlying":"Ordinary Shares","underlying_shares":20004},"source":{"system":"sec-edgar","filing":"0001645113-21-000030","document":"wf-form4_161489829589176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000030/wf-form4_161489829589176.xml","form_type":"4"}},{"id":2808847,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-04T22:52:16.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":10886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units that are scheduled to vest in equal installments on each of March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":38135,"source":{"system":"sec-edgar","filing":"0001645113-21-000030","document":"wf-form4_161489829589176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000030/wf-form4_161489829589176.xml","form_type":"4"}},{"id":2808846,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2021-03-04T22:52:16.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":428,"price":152.053,"value":65078.684,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Share Units vested on February 27, 2021.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":27249,"source":{"system":"sec-edgar","filing":"0001645113-21-000030","document":"wf-form4_161489829589176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000030/wf-form4_161489829589176.xml","form_type":"4"}},{"id":2820147,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-02T21:14:31.000Z","date":"2021-02-27","kind":"exercise","acquired":false,"shares":1465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-02-27","underlying":"Ordinary Shares","underlying_shares":1465},"source":{"system":"sec-edgar","filing":"0001645113-21-000022","document":"wf-form4_161471962569346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000022/wf-form4_161471962569346.xml","form_type":"4"}},{"id":2820146,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-02T21:14:31.000Z","date":"2021-02-27","kind":"exercise","acquired":true,"shares":1465,"price":149.1,"value":218431.5,"ownership":{"direct":true},"balance_after":27677,"source":{"system":"sec-edgar","filing":"0001645113-21-000022","document":"wf-form4_161471962569346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000022/wf-form4_161471962569346.xml","form_type":"4"}},{"id":2994843,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-03T21:23:07.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":230,"price":117.411,"value":27004.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the  vesting of restricted stock units.  This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":26212,"source":{"system":"sec-edgar","filing":"0001645113-20-000158","document":"wf-form4_160443857426133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000158/wf-form4_160443857426133.xml","form_type":"4"}},{"id":3037781,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-09-04T20:38:01.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 11,336 ordinary shares will vest and become exercisable in equal installments on each of September 1, 2021, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates."}],"balance_after":11336,"derivative":{"exercise_price":84.68,"expiration_date":"2030-08-31","underlying":"Ordinary Shares","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001645113-20-000129","document":"wf-form4_159925186640377.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000129/wf-form4_159925186640377.xml","form_type":"4"}},{"id":3037780,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62545,"kind":"person","name":"Cordova Ashley","position":1,"cik":"0001822014","reported_name":"Cordova Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2020-09-04T20:38:01.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":5904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on September 1, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates."}],"balance_after":26442,"source":{"system":"sec-edgar","filing":"0001645113-20-000129","document":"wf-form4_159925186640377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000129/wf-form4_159925186640377.xml","form_type":"4"}}]}